(Q43751910)

26 November 2017

title

Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates (English)

1 reference

26 November 2017

1 reference

Ana Luiza N Junqueira

1

1 reference

26 November 2017

Viviane R Tavares

2

1 reference

26 November 2017

Regina M B Martins

3

1 reference

26 November 2017

Kamilla V Frauzino

4

1 reference

26 November 2017

Agabo M da Costa e Silva

5

1 reference

26 November 2017

Izolina M X Rodrigues

6

1 reference

26 November 2017

Ruth Minamisava

7

1 reference

26 November 2017

Sheila A Teles

8

1 reference

26 November 2017

publication date

1 February 2011

1 reference

Memórias do Instituto Oswaldo Cruz

26 November 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 November 2017

volume

106

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

113-116

1 reference

Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Benefits of early hepatitis B immunization programs for newborns and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

The global impact of vaccination against hepatitis B: a historical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100018

10.1590/S0074-02762011000100018

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference